Cargando…
Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present coho...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226544/ https://www.ncbi.nlm.nih.gov/pubmed/34070592 http://dx.doi.org/10.3390/diagnostics11060946 |
_version_ | 1783712312041930752 |
---|---|
author | Partl, Richard Lukasiak, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Stranzl-Lawatsch, Heidi Langsenlehner, Tanja |
author_facet | Partl, Richard Lukasiak, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Stranzl-Lawatsch, Heidi Langsenlehner, Tanja |
author_sort | Partl, Richard |
collection | PubMed |
description | There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present cohort study was to investigate the association between inflammation-based parameters and the sphincter-preserving surgery rate in patients with low-lying locally advanced rectal cancer (LARC). A total of 848 patients with LARC undergoing radiotherapy from 2004 to 2019 were retrospectively reviewed in order to identify patients with rectal cancer localized ≤6 cm from the anal verge, treated with neo-adjuvant radiochemotherapy (nRCT) and subsequent surgery. Univariable and multivariable analyses were used to investigate the role of pre-treatment inflammatory parameters, including the C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the prediction of sphincter preservation. A total of 363 patients met the inclusion criteria; among them, 210 patients (57.9%) underwent sphincter-preserving surgery, and in 153 patients (42.1%), an abdominoperineal rectum resection was performed. Univariable analysis showed a significant association of the pre-treatment CRP value (OR = 2.548, 95% CI: 1.584–4.097, p < 0.001) with sphincter preservation, whereas the pre-treatment NLR (OR = 1.098, 95% CI: 0.976–1.235, p = 0.120) and PLR (OR = 1.002, 95% CI: 1.000–1.005, p = 0.062) were not significantly associated with the type of surgery. In multivariable analysis, the pre-treatment CRP value (OR = 2.544; 95% CI: 1.314–4.926; p = 0.006) was identified as an independent predictive factor for sphincter-preserving surgery. The findings of the present study suggest that the pre-treatment CRP value represents an independent parameter predicting the probability of sphincter-preserving surgery in patients with low-lying LARC. |
format | Online Article Text |
id | pubmed-8226544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82265442021-06-26 Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? Partl, Richard Lukasiak, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Stranzl-Lawatsch, Heidi Langsenlehner, Tanja Diagnostics (Basel) Article There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present cohort study was to investigate the association between inflammation-based parameters and the sphincter-preserving surgery rate in patients with low-lying locally advanced rectal cancer (LARC). A total of 848 patients with LARC undergoing radiotherapy from 2004 to 2019 were retrospectively reviewed in order to identify patients with rectal cancer localized ≤6 cm from the anal verge, treated with neo-adjuvant radiochemotherapy (nRCT) and subsequent surgery. Univariable and multivariable analyses were used to investigate the role of pre-treatment inflammatory parameters, including the C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the prediction of sphincter preservation. A total of 363 patients met the inclusion criteria; among them, 210 patients (57.9%) underwent sphincter-preserving surgery, and in 153 patients (42.1%), an abdominoperineal rectum resection was performed. Univariable analysis showed a significant association of the pre-treatment CRP value (OR = 2.548, 95% CI: 1.584–4.097, p < 0.001) with sphincter preservation, whereas the pre-treatment NLR (OR = 1.098, 95% CI: 0.976–1.235, p = 0.120) and PLR (OR = 1.002, 95% CI: 1.000–1.005, p = 0.062) were not significantly associated with the type of surgery. In multivariable analysis, the pre-treatment CRP value (OR = 2.544; 95% CI: 1.314–4.926; p = 0.006) was identified as an independent predictive factor for sphincter-preserving surgery. The findings of the present study suggest that the pre-treatment CRP value represents an independent parameter predicting the probability of sphincter-preserving surgery in patients with low-lying LARC. MDPI 2021-05-25 /pmc/articles/PMC8226544/ /pubmed/34070592 http://dx.doi.org/10.3390/diagnostics11060946 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Partl, Richard Lukasiak, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Stranzl-Lawatsch, Heidi Langsenlehner, Tanja Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title | Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title_full | Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title_fullStr | Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title_full_unstemmed | Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title_short | Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? |
title_sort | can pre-treatment inflammatory parameters predict the probability of sphincter-preserving surgery in patients with locally advanced low-lying rectal cancer? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226544/ https://www.ncbi.nlm.nih.gov/pubmed/34070592 http://dx.doi.org/10.3390/diagnostics11060946 |
work_keys_str_mv | AT partlrichard canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT lukasiakkatarzyna canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT stranzbettina canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT hasslereva canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT magyarmarton canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT stranzllawatschheidi canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer AT langsenlehnertanja canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer |